Mezzion Pharma Co.Ltd (140410) - Total Liabilities

Latest as of March 2026: ₩83.41 Billion KRW ≈ $56.53 Million USD

Based on the latest financial reports, Mezzion Pharma Co.Ltd (140410) has total liabilities worth ₩83.41 Billion KRW (≈ $56.53 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore investment intensity of Mezzion Pharma Co.Ltd to see how much of total assets are deployed in long-term investments.

Mezzion Pharma Co.Ltd - Total Liabilities Trend (2012–2025)

This chart illustrates how Mezzion Pharma Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of Mezzion Pharma Co.Ltd.

Mezzion Pharma Co.Ltd Competitors by Total Liabilities

The table below lists competitors of Mezzion Pharma Co.Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Zhejiang Jianfeng Group Co Ltd SHG:600668	China	CN¥2.00 Billion
Trade-Van Information Services Co TW:6183	Taiwan	NT$1.78 Billion
PCL Technologies Inc TW:4977	Taiwan	NT$1.25 Billion
Tecnon Fujian Commercial Lighting Co Ltd SHE:300650	China	CN¥941.87 Million
Summit Midstream Corporation NYSE:SMC	USA	$1.49 Billion
Posiflex Technology Inc TW:8114	Taiwan	NT$6.51 Billion
Huchems KO:069260	Korea	₩259.89 Billion
John Wiley & Sons B NYSE:WLYB	USA	$1.74 Billion

Liability Composition Analysis (2012–2025)

This chart breaks down Mezzion Pharma Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 140410 net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.47	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	5.38	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.84	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Mezzion Pharma Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Mezzion Pharma Co.Ltd (2012–2025)

The table below shows the annual total liabilities of Mezzion Pharma Co.Ltd from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩80.83 Billion ≈ $54.78 Million	+189.35%
2024-12-31	₩27.94 Billion ≈ $18.93 Million	-9.02%
2023-12-31	₩30.70 Billion ≈ $20.81 Million	+10.52%
2022-12-31	₩27.78 Billion ≈ $18.83 Million	+31.41%
2021-12-31	₩21.14 Billion ≈ $14.33 Million	+12.36%
2020-12-31	₩18.82 Billion ≈ $12.75 Million	+17.28%
2019-12-31	₩16.04 Billion ≈ $10.87 Million	-9.56%
2018-12-31	₩17.74 Billion ≈ $12.02 Million	-14.99%
2017-12-31	₩20.87 Billion ≈ $14.14 Million	-51.57%
2016-12-31	₩43.09 Billion ≈ $29.20 Million	+6.35%
2015-12-31	₩40.52 Billion ≈ $27.46 Million	+921.54%
2012-12-31	₩3.97 Billion ≈ $2.69 Million	--

About Mezzion Pharma Co.Ltd

KQ:140410 Korea Pharmaceuticals

Market Cap

$429.17 Million

₩633.28 Billion KRW

Market Cap Rank

#13136 Global

#378 in Korea

Share Price

₩74100.00

Change (1 day)

+2.77%

52-Week Range

₩51000.00 - ₩172700.00

All Time High

₩172700.00